ProCE Banner Activity

How I See the Role of PARP Inhibitors Changing in Pancreatic Cancer

Clinical Thought
How might the use of PARP inhibitors evolve in the treatment of pancreatic cancer? Read this commentary from Dr Philip Philip.

Released: January 31, 2022

Expiration: January 30, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca